Machine Learning–Based Diagnostic Imaging Platforms Market: Analysis 2031

According to a research study published by Knowledge Sourcing Intelligence (KSI), the machine learning–based diagnostic imaging platforms market will expand from USD 2.1 billion in 2026 to USD 5.1 billion in 2031 at a CAGR of 19.4% during the forecast period.

The market is expected to experience strong growth because medical imaging facilities are adopting artificial intelligence technology for medical diagnosis purposes.

Access sample report or view details: https://www.knowledge-sourcing.com/report/machine-learningbased-diagnostic-imaging-platforms-market/request

Key Market Insight & Emerging Trends:

The diagnostic accuracy of radiology workflows improves through the implementation of machine learning algorithms because it enables faster diagnosis results. AI platforms help healthcare organizations manage their increasing imaging demands, which result from their need to overcome the shortage of available radiologists. The worldwide adoption of AI imaging tools has accelerated because healthcare organizations received regulatory approval for these technologies, while digital health infrastructure investments increased.

Additionally, tele-radiology services and cloud-based imaging systems enable healthcare organizations to conduct remote diagnostics while their professionals share information in real time. The rising number of patients with chronic conditions like cancer, cardiovascular disorders, and neurological diseases is increasing the need for better imaging technology.

The Asia Pacific region shows strong growth potential because its healthcare facilities expand, its government programs support AI technology adoption, and its large patient base.

North America maintained market leadership in 2026 through its substantial market share.
The software segment will experience the fastest growth during the upcoming years because deep learning model technology continues to make progress.
CT and MRI imaging methods will become the dominant modalities for complex disease assessments because of their widespread usage.
The oncology application segment will become the largest market segment because of rising cancer rates and the demand for early cancer detection.

Market leaders are pursuing AI research and development while forming strategic partnerships and obtaining regulatory approvals to increase their market presence. Meanwhile, emerging startups are also playing a crucial role by developing niche AI solutions for specific imaging applications.

Component Insights: Software Segment at the Forefront

The software segment held the greatest market share during 2026 because it provided essential functionalities needed for image analysis and pattern recognition, and clinical decision support. AI-powered software enables automation of workflows, which leads to better diagnostic results while decreasing the possibility of human mistakes. Increasing usage of cloud-based AI platforms creates additional opportunities for the segment to expand.

Modality Insights: CT Imaging as a Core Revenue Contributor

Computed Tomography (CT) modality dominates the market because it serves as the primary method for identifying complex medical conditions, which include tumors and cardiovascular abnormalities. The introduction of machine learning to CT systems allows for quicker image analysis and more accurate results through advanced diagnostic capabilities.

Application Insights: Oncology Driving Maximum Adoption

Oncology remains the leading application segment as Machine Learning technology is used for early tumor detection and treatment planning, and monitoring activities drive oncological research advancement. The segment grows because patients need precise treatment solutions, which is driven by rising global cancer rates.

Regional Highlights: North America Leading, Asia Pacific Accelerating

North America controls a substantial market share as the region possesses superior healthcare facilities and advanced AI systems, and major technology companies establish their operations there. The market expansion in the region receives support from research and development funding, together with business-friendly regulatory environments. The Asia Pacific region will experience rapid growth throughout the forecasted period because of its rising digital health projects and growing healthcare technology accessibility.

Competitive Landscape

As a part of the report, the major players operating in the machine learning–based diagnostic imaging platforms market have been covered, such as Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, Fujifilm Healthcare, IBM Watson Health, Aidoc, Zebra Medical Vision, Tempus, and Butterfly Network. These companies are actively engaged in product launches, partnerships, and technological advancements to expand their AI imaging portfolios and strengthen their global presence.

Market Segmentation

The report segments the Machine Learning–Based Diagnostic Imaging Platforms Market as follows:

By Component

o Software

o Hardware

o Services

By Imaging Modality

o X-ray

o Computed Tomography (CT)

o Magnetic Resonance Imaging (MRI)

o Ultrasound

o Positron Emission Tomography (PET)

o Mammography

By Application

o Oncology

o Cardiology

o Neurology

o Orthopedics

o Pulmonology

By Geography
- North America
  - USA
  - Canada
  - Mexico
- South America
  - Brazil
  - Argentina
  - Others
- Europe
  - United Kingdom
  - Germany
  - France
  - Spain
  - Others
- Middle East and Africa
  - Saudi Arabia
  - UAE
  - Others
- Asia Pacific
  - China
  - India
  - Japan
  - South Korea
  - Indonesia
  - Thailand
  - Others